Advertisement
Research Article Free access | 10.1172/JCI103412
Department of Psychiatry of The Johns Hopkins Hospital, Baltimore, Md.
1This investigation, under the direction of Dr. John C. Whitehorn, was supported by a research grant (M-1085) from the National Institute of Mental Health of the National Institutes of Health, Public Health Service.
2The glucagon employed in this study was kindly supplied by Dr. W. R. Kirtley of Eli Lilly and Company. Portions of lots numbered 208-158B-214, 208-158B-214A, and 258-234B-30A were included.
Find articles by Schulman, J. in: PubMed | Google Scholar
Department of Psychiatry of The Johns Hopkins Hospital, Baltimore, Md.
1This investigation, under the direction of Dr. John C. Whitehorn, was supported by a research grant (M-1085) from the National Institute of Mental Health of the National Institutes of Health, Public Health Service.
2The glucagon employed in this study was kindly supplied by Dr. W. R. Kirtley of Eli Lilly and Company. Portions of lots numbered 208-158B-214, 208-158B-214A, and 258-234B-30A were included.
Find articles by Greben, S. in: PubMed | Google Scholar
Published January 1, 1957 - More info